Sleep Apnea
Conditions
Keywords
steroids, patients treated with systemic steroids
Brief summary
Weight gain is both a significant risk factor for obstructive sleep apnea and a side-effect of long-term systemic steroids therapy. This study aimed to investigate the impact of long-term systemic steroid treatment on sleep apnea.
Interventions
OTHERsleep study
The polysomnography (PSG) (Alice 3 System; Healthdyne, Atlanta, GA) consisted of continuous polygraphic recording from surface leads for electroencephalography, electrooculography, electromyography, electrocardiography, thermistors for nasal and oral airflow, thoracic and abdominal impedance belts for respiratory effort, pulse oximeter for oxyhemoglobin level, tracheal microphone for snoring, and sensors for leg and sleep position
Sponsors
Israeli association for lung disease
Rambam Health Care Campus
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* For inclusion, a scheduled therapy with a minimum daily dose of 10 mg prednisone (or equivalent) for at least 3 months was required
Exclusion criteria
* Patients younger than 18 years and those with known sleep apnea or other forms of sleep-disordered breathing were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| apnea-hypopnea index | 3 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| sleep study variables | 3 months | apnea-hypopnea interval desaturation at the end of apnea interval snoring intensity |
Countries
Israel
Outcome results
None listed